- Pharming press release (NASDAQ:PHAR): Q4 revenues of US$81.2 million.
- RUCONEST revenues of US$73.3 million.
- EPS US$0.004.
- 2024 total revenue guidance of US$280 million – US$295 million.
Pharming reports Q4 results
Recommended For You
More Trending News
About PHAR Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| PHAR | - | - |
| Pharming Group N.V. | ||